ArticleTherapeutic advances in infectious disease

Substance use disorder-associated infections' treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) - an investigator-initiated single-arm unblinded prospective cohort study.

Martin Krsak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.